The SOVRYN Standard
What We Don’t Prescribe, and Why.
A formulary is a list of what clinicians are allowed to prescribe. Ours is deliberately narrow. Here are the criteria a medication must meet to be on it, and the kinds of products we will not prescribe even when they are easy to find online.
Formulary Criteria
What a Medication Must Meet to Be on Our Formulary.
- 01
A Stated Regulatory Status
We can say plainly whether it is FDA-approved, compounded, or on an FDA compounding list, and that status is shown beside the price.
- 02
A Named, Licensed Pharmacy
It comes from a pharmacy licensed in your state under the right framework, and the pharmacy that fills your prescription is identified in your care plan.
- 03
Evidence We Can Describe Honestly
We have reviewed what is published, and we can say where it is strong, where it is preclinical and where it is missing.
- 04
A Defined Monitoring Plan
We know what will be measured, how often, and what result would lead us to adjust or stop.
- 05
A Plan for Stopping
Maintenance, taper or discontinuation is planned before the first dose, not improvised after.
- 06
Screening for Sport and Work
Where anti-doping or aviation rules can apply, we ask first, before options are shown.
- 07
Clinical Sign-Off and Re-Review
Our clinical team approves it for the formulary and revisits that decision as the evidence and the rules change.
What We Do Not Prescribe
Six Lines We Hold.
Products Sold for "Research Use Only"
Anything labeled for research, investigational or laboratory use, or "not for human use," is not a medication for patient care. We prescribe only through licensed pharmacies, for an individual patient, after clinician review.
Anything Without a Named Pharmacy Source
If we cannot tell you who prepared it, where, and under which license, we do not prescribe it.
Prescriptions Without a Clinical Evaluation
A form or a request is not an evaluation. Every prescription follows a clinician's review of your history, medications and labs where indicated.
Compounds Where We Cannot State the Regulatory Status
If we cannot show an approval or a compounding-list status beside the price, it does not go on a care plan.
Options That Would Put a Tested Athlete or Pilot at Risk
A prescription does not establish eligibility in a tested sport or for flying. We screen first, and we do not present options that the rules you are bound by prohibit.
Products Whose Claims Outrun Their Evidence
We do not prescribe on the strength of marketing, anecdotes or a protocol we cannot defend. Where evidence is thin, it is an exception we explain, not a headline.
Under Clinical Review
Compounds and combinations that are not listed on a SOVRYN care plan are not prescribed. If you are asking about one, our medical team reviews the evidence, the source and the monitoring plan before it is ever added, and until then the answer is no.
How We Treat Each Status
Regulatory Status Is Shown, Not Hidden.
Every item on our formulary carries one of these statuses beside its price. The status tells you what the label does and does not mean.
The medication itself is FDA-approved. Approval covers labeled indications, and any other use is clinician-directed and explained to you as off-label.
Made by a licensed pharmacy for you individually. Not FDA-approved and not evaluated for safety, effectiveness or quality, so we say which ones are and why we chose them.
On FDA's interim Category 1 compounding list. A policy classification, not an approval and not proof that it works.
Flagged on FDA's Category 2 safety-risk review list. We treat it as monitored and describe the evidence as limited, and availability may change at any time.
Human evidence is limited or mostly preclinical. We say so before you start and define how we will judge whether it is helping.
On the Formulary Today
What We Do Prescribe.
| Medication | Regulatory Status | |
|---|---|---|
| Compounded Tirzepatide | Compounded · not FDA-approved | Details → |
| BPC-157 | ●Category 2 · under review | Details → |
| NAD+ Therapy | Category 1 | Details → |
| Compounded Semaglutide | Compounded · not FDA-approved | Details → |
| CJC-1295 and Ipamorelin | ●Category 2 · under review | Details → |
| Tesamorelin | Compounded · not FDA-approved | Details → |
| Tadalafil | FDA-approved medication | Details → |
| PT-141 (Bremelanotide) | Compounded · not FDA-approved | Details → |
| Glutathione | Limited evidence | Details → |
| Wolverine | Limited evidence | Details → |
| GLOW | Limited evidence | Details → |
| KLOW | Limited evidence | Details → |
| CJC-1295 | ●Category 2 · under review | Details → |
| Ipamorelin | ●Category 2 · under review | Details → |
| Sermorelin | Compounded · not FDA-approved | Details → |
| TB-500 | ●Category 2 · under review | Details → |
| GHK-Cu | Limited evidence | Details → |
| KPV | ●Category 2 · under review | Details → |
| Thymosin Alpha-1 | Limited evidence | Details → |
| Epitalon | ●Category 2 · under review | Details → |
| MOTS-c | ●Category 2 · under review | Details → |
| 5-Amino-1MQ | Limited evidence | Details → |
Compounded medications are not FDA-approved or evaluated for safety, effectiveness or quality. Availability varies by state and can change as regulations change.
Asking About Something Not Listed?
Tell our care team what you have heard about. We will tell you where it stands and why it is, or is not, on our formulary.